{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:27:15Z","timestamp":1770280035140,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T00:00:00Z","timestamp":1699488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s00277-023-05494-x","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T02:01:36Z","timestamp":1699495296000},"page":"37-59","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Investigating the correlation between small molecular inhibitor utilization, peripheral blood monocytes, and treatment outcomes in Rosai Dorfman disease"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8652-183X","authenticated-orcid":false,"given":"Samuel B.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabrina","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asra Z.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,9]]},"reference":[{"issue":"26","key":"5494_CR1","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","volume":"131","author":"O Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF et al (2018) Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood 131(26):2877\u20132890","journal-title":"Blood"},{"issue":"1","key":"5494_CR2","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1016\/j.clml.2020.08.007","volume":"21","author":"HA Salama","year":"2021","unstructured":"Salama HA, Jazieh AR, Alhejazi AY, Absi A, Alshieban S, Alzahrani M et al (2021) Highlights of the Management of adult histiocytic disorders: Langerhans cell histiocytosis, Erdheim-Chester disease, Rosai-Dorfman disease, and hemophagocytic lymphohistiocytosis. Clin Lymphoma Myeloma Leuk 21(1):e66\u2013e75","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"15","key":"5494_CR3","doi-asserted-by":"publisher","first-page":"3984","DOI":"10.1182\/bloodadvances.2022009013","volume":"7","author":"A Aaroe","year":"2023","unstructured":"Aaroe A, Kurzrock R, Goyal G, Goodman AM, Patel H, Ruan G et al (2023) Successful treatment of non-Langerhans cell histiocytosis with the MEK inhibitor trametinib: a multicenter analysis. Blood Adv 7(15):3984\u20133992","journal-title":"Blood Adv"},{"key":"5494_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.7150\/jca.1.80","volume":"1","author":"CM Costelloe","year":"2010","unstructured":"Costelloe CM, Chuang HH, Madewell JE, Ueno NT (2010) Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 1:80\u201392","journal-title":"J Cancer"},{"issue":"12","key":"5494_CR5","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1001\/jamaoncol.2022.4432","volume":"8","author":"JP Abeykoon","year":"2022","unstructured":"Abeykoon JP, Rech KL, Young JR, Ravindran A, Ruan GJ, Dasari S et al (2022) Outcomes after treatment with cobimetinib in patients with Rosai-Dorfman disease based on KRAS and MEK alteration status. JAMA Oncol 8(12):1816\u20131820","journal-title":"JAMA Oncol"},{"issue":"9","key":"5494_CR6","first-page":"904","volume":"49","author":"RF Dong","year":"2020","unstructured":"Dong RF, Gong LH, Zhang W, Li L, Sun XQ, Zhang M et al (2020) Primary intraosseous Rosai-Dorfman disease: a clinicopathological analysis of fourteen cases. Zhonghua Bing Li Xue Za Zhi 49(9):904\u2013909","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"5494_CR7","doi-asserted-by":"publisher","first-page":"950114","DOI":"10.3389\/fonc.2022.950114","volume":"12","author":"X Weng","year":"2022","unstructured":"Weng X, Yang Y, Zhang M, Cai C, Sun Y, Wu X et al (2022) Primary intraosseous Rosai-Dorfman disease: an analysis of clinicopathologic characteristics, molecular genetics, and prognostic features. Front Oncol 12:950114","journal-title":"Front Oncol"},{"issue":"3","key":"5494_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/MD.0000000000000030","volume":"93","author":"JD Sandoval-Sus","year":"2014","unstructured":"Sandoval-Sus JD, Sandoval-Leon AC, Chapman JR, Velazquez-Vega J, Borja MJ, Rosenberg S et al (2014) Rosai-Dorfman disease of the central nervous system: report of 6 cases and review of the literature. Med Balt 93(3):165\u2013175","journal-title":"Med Balt"},{"issue":"2","key":"5494_CR9","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/JLB.4RI0818-311R","volume":"106","author":"CE Olingy","year":"2019","unstructured":"Olingy CE, Dinh HQ, Hedrick CC (2019) Monocyte heterogeneity and functions in cancer. J Leukoc Biol 106(2):309\u2013322","journal-title":"J Leukoc Biol"},{"issue":"11","key":"5494_CR10","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1007\/s00277-018-3436-0","volume":"97","author":"A Tzankov","year":"2018","unstructured":"Tzankov A, Kremer M, Leguit R, Orazi A, van der Walt J, Gianelli U et al (2018) Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016. Ann Hematol 97(11):2117\u20132128","journal-title":"Ann Hematol"},{"key":"5494_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.molimm.2021.05.009","volume":"136","author":"MLM Jongsma","year":"2021","unstructured":"Jongsma MLM, Neefjes J, Spaapen RM (2021) Playing hide and seek: tumor cells in control of MHC class I antigen presentation. Mol Immunol 136:36\u201344","journal-title":"Mol Immunol"},{"issue":"7","key":"5494_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11912-019-0810-6","volume":"21","author":"M Papo","year":"2019","unstructured":"Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF et al (2019) Systemic histiocytosis (Langerhans cell histiocytosis, Erdheim-Chester disease, Destombes-Rosai-Dorfman disease): from oncogenic mutations to inflammatory disorders. Curr Oncol Rep 21(7):62","journal-title":"Curr Oncol Rep"},{"issue":"19","key":"5494_CR13","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","volume":"117","author":"E Campo","year":"2011","unstructured":"Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood. 117(19):5019\u201332","journal-title":"Blood."},{"issue":"10","key":"5494_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","volume":"30","author":"S Garces","year":"2017","unstructured":"Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J et al (2017) Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 30(10):1367\u20131377","journal-title":"Mod Pathol"},{"issue":"6","key":"5494_CR15","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1158\/1535-7163.MCT-18-1244","volume":"18","author":"F Janku","year":"2019","unstructured":"Janku F, Diamond EL, Goodman AM, Raghavan VK, Barnes TG, Kato S et al (2019) Molecular profiling of tumor tissue and plasma cell-free DNA from patients with non-Langerhans cell histiocytosis. Mol Cancer Ther 18(6):1149\u20131157","journal-title":"Mol Cancer Ther"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05494-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05494-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05494-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T18:05:11Z","timestamp":1704218711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05494-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,9]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["5494"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05494-x","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,9]]},"assertion":[{"value":"8 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did involve human participants and was performed under the University of Michigan Institutional Review Board (IRB) study ID HUM00214315. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable for this publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}